Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Semaglutide Side Effects: Ozempic, Wegovy & Rybelsus Complete Guide (2026)
guideSemaglutide side effects guide: nausea, diarrhea, and GI symptoms from STEP and SUSTAIN trials, plus practical management tips.
GLP-1 Side Effects: Retatrutide, Tirzepatide & Semaglutide Compared
guideRetatrutide side effects guide: nausea, diarrhea, and other GI symptoms from Phase 2 clinical trial data, plus management strategies.
Retatrutide Nausea Management: How to Reduce GI Side Effects
articleA practical retatrutide nausea management guide covering the mechanism, Phase 2 trial data, the dose step-back protocol, and dietary strategies.
Zepbound Side Effects: Complete Guide for Weight Loss Patients
guideZepbound side effects guide: nausea 25-29%, diarrhea 19-23%, symptom timeline, serious warnings, and practical management tips for weight loss patients.
Tirzepatide Side Effects: What to Expect & How to Manage (2026 Guide)
guideTirzepatide side effects guide: nausea, diarrhea, and other GI symptoms from clinical trial data, plus practical management tips.
Semaglutide Nausea Management: What the Wegovy Label Says
articleA semaglutide nausea management guide built on the Wegovy label's own numbers and escalation language, not generic tips.